Management challenges and therapeutic advances in congenital adrenal hyperplasia

Treatment for congenital adrenal hyperplasia (CAH) was introduced in the 1950s following the discovery of the structure and function of adrenocortical hormones. Although major advances in molecular biology have delineated steroidogenic mechanisms and the genetics of CAH, management and treatment of...

Descripción completa

Detalles Bibliográficos
Autores principales: Mallappa, Ashwini, Merke, Deborah P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999997/
https://www.ncbi.nlm.nih.gov/pubmed/35411073
http://dx.doi.org/10.1038/s41574-022-00655-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8999997/
https://www.ncbi.nlm.nih.gov/pubmed/35411073
http://dx.doi.org/10.1038/s41574-022-00655-w

Ejemplares similares